Dtsch Med Wochenschr 2019; 144(04): 276-281
DOI: 10.1055/a-0759-7180
© Georg Thieme Verlag KG Stuttgart · New York

Genom-Editierung mit CRISPR/Cas9: Vorzeichen einer neuen Epoche der Medizin?

Genome Editing with CRISPR/Cas9: First Steps Towards a new Era in Medicine?
Bernhard Schermer
Thomas Benzing
Further Information

Publication History

Publication Date:
13 February 2019 (online)


The emergence of genome editing technologies can be regarded as one of the most groundbreaking revolutions in the history of science. Modern genome editing allows the introduction of precise mutations into the genome of virtually all cells and organisms without leaving any additional trace. Undoubtedly, genome editing with CRISPR/Cas9, often casually referred to as “genetic scissors”, will revolutionize medical research and development. However, at the same time it creates a great need for ethical considerations as it might hold risks for both people and the environment that cannot yet be fully assessed. While genome editing is already well established in laboratory research, clinical applications based on genome editing are close. For the first time, targeted corrections of genetic defects in somatic cells, stem cells as well as in the germ line appear technically feasible. This generates possible future scenarios that urgently require broad ethical and social discussions.

Mit einfachen Mitteln lassen sich inzwischen präzise Änderungen am Genom von Zellen und Organismen vornehmen. Die Technologie der Genom-Editierung ist in der Grundlagenforschung bereits fest etabliert – der Einzug der Methodik in die klinische Medizin steht kurz bevor. Diese Revolution der Wissenschaftsgeschichte macht eine breite ethische Diskussion unumgänglich.